taprostene has been researched along with Shock--Septic* in 2 studies
2 other study(ies) available for taprostene and Shock--Septic
| Article | Year |
|---|---|
The prostacyclin analogue taprostene and recombinant human superoxide dismutase increase the permanent survival rate of endotoxemic rats.
The permanent survival rate of endotoxemic rats was studied. In 40 untreated control rats the survival rate 7 days after the endotoxin administration was 33%. The survival rate was increased to 40% with recombinant human superoxide dismutase (r-HSOD), to 55% (p less than 0.05) with the prostacyclin analogue Taprostene and to 70% (p less than 0.01) with the combination of r-HSOD and Taprostene (20 rats for each treatment group). r-HSOD and Taprostene provide significant and permanent protection in rat endotoxic shock. Topics: Animals; Chi-Square Distribution; Drug Synergism; Endotoxins; Epoprostenol; Lung; Male; Rats; Rats, Inbred Strains; Recombinant Proteins; Shock, Septic; Superoxide Dismutase; Survival Rate | 1990 |
Pentoxifylline increases survival of mice in endotoxic shock.
Topics: Animals; Epoprostenol; Female; Indomethacin; Leukopenia; Lipopolysaccharides; Mice; Pentoxifylline; Prostaglandins, Synthetic; Shock, Septic; Theobromine | 1989 |